Radixact and Helix boost flexible helical radiotherapy, Accuray introduces advanced options at ESTRO26

Radixact and Helix boost flexible helical radiotherapy, Accuray introduces advanced options at ESTRO26
Accuray unveils Radixact at ESTRO26

Accuray introduces enhanced flexibility and confidence in helical treatment delivery with its Radixact and Accuray Helix solutions at ESTRO26.

The company is focusing on advancing radiotherapy technologies, aiming to improve precision and patient outcomes. The announcement at ESTRO26 highlights Accuray's commitment to innovation in cancer treatment through state-of-the-art equipment.

Accuray has previously reported clinical outcomes with its systems. A company study found that helical TomoTherapy delivered less xerostomia than VMAT in patients with advanced nasopharyngeal carcinoma. The results were linked to improved sparing of the parotid glands during treatment.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.